about
Number of patients studied prior to approval of new medicines: a database analysisIncreased risk of sudden cardiac arrest in obstructive pulmonary disease: a case-control studyData management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review.Use of metformin and survival of diabetic women with breast cancerRandomized controlled trials of COX-2 inhibitors: an analysis of doses used and trends over time to investigate implications for comparative safety.Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data.Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registryUse of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.Epidemiology of adverse drug reactions in Europe: a review of recent observational studiesRisk of bladder cancer in patients with diabetes: a retrospective cohort study.In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugsAn analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe.Diabetes and Breast Cancer Subtypes.Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research.Classification of Recombinant Biologics in the EU: Divergence Between National Pharmacovigilance CentersInfluence of metformin intake on the risk of bladder cancer in type 2 diabetes patients.Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports.Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®Insulin glargine use and breast cancer risk: Associations with cumulative exposureFertility in female childhood cancer survivors.The post hoc use of randomised controlled trials to explore drug associated cancer outcomes: methodological challenges.Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications.Traceability of biologicals: present challenges in pharmacovigilance.Validity of diagnostic codes and laboratory measurements to identify patients with idiopathic acute liver injury in a hospital database.Strategy in Regulatory Decision-Making for Management of Progressive Multifocal Leukoencephalopathy.Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013.The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study.Trends in breast cancer incidence among women with type-2 diabetes in British general practice.Lessons learned on the design and the conduct of Post-Authorization Safety Studies: review of 3 years of PRAC oversight.Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.The risk of acute liver injury associated with the use of antibiotics--evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project.Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU.When more is less - An exploratory study of the precautionary reporting bias and its impact on safety signal detection.Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.Incidence of adverse events among healthcare workers following H1N1 Mass immunization in Ghana: a prospective study.Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project.
P50
Q28488191-352F9F93-ECA2-4A4A-B333-2D0D0B43553CQ28533685-9B5E6BFA-4265-450F-84DE-EB0C149511E6Q30980437-A10A8968-8EB4-4690-AA79-5F411E00553FQ33646542-F3DEA40C-BD0C-4209-83FB-E56EBE2A6F6CQ33989306-2C11282D-00DB-4B6B-B9E4-A47ED8F020E8Q34086275-184CF789-239B-4F81-80D1-2981406CA104Q34304828-9A140084-97E1-4ACC-90D0-7AC7F585BCAEQ35038355-D83FED99-636A-4A00-A30A-5472F4857A7CQ35546999-94A82813-826B-4866-9CD3-BAA617742DC4Q35691835-116DAC6D-5BAC-49D6-B145-65B4B991687BQ36024396-E28C3A33-0BFB-4C55-AB80-583ACFED5C47Q36042939-AD1E34AF-1937-438D-9308-ED2D42ABB8D8Q36246468-A183BE68-0FF2-4158-ACCE-EFD0C9A9F3B9Q36314370-34974643-1AC2-4440-93BF-52616CE20B51Q36385526-84F0A0D7-64F9-46EC-9C98-2C8D4A04F6E3Q36410079-7F6DB41A-88FE-4034-B6A4-0B970AB34ED1Q36472011-27049D90-FDAB-478E-8C75-4B2B05B32634Q36526958-1733F20D-6A99-4FB9-97E8-F39FD13360A6Q36698851-7597D3EB-5A48-4C57-A3A6-5546964C75BBQ37154820-CD82011C-FAF4-4F58-9505-4FDDFF8845A3Q37417043-44A8896D-FD0D-46C9-B842-5C2F13BE5829Q38161541-25AC977B-5E14-4BCF-977F-2E138A96E3E3Q38209071-BEB8F1A5-36DA-44EB-AD32-81877C5C2A22Q38264987-E1E6203F-B74A-4048-996C-2DDD9FC65450Q38543135-87299F97-BA8C-46D1-890B-05E5BB6E88B8Q38562161-BDC70DCD-5C8B-4064-9E49-B5943FE811A3Q38874834-D54A0209-C42E-47B2-80DA-E0D94D6C82BDQ38931121-DC0357EF-E6E8-427D-8772-4C700DC520F5Q38942058-725A312A-C1BB-45AB-B17D-541965CB39A1Q38990529-D01EF139-CE0B-489E-BC85-F55D79A12E49Q39156623-F020F222-6FE3-4F0B-8CB8-8BF7A92295CDQ39540384-4629AB94-2B68-4C2E-991D-DD79BB192CF3Q39869513-80B2D4C3-5CD0-47DA-9809-E8CF8C535198Q39908428-9A5AC1F0-1BF7-4293-9468-D3F7A2AA835EQ40039461-A37E4050-28B1-462A-A2C3-99C38D94B7AAQ40049393-19707213-B582-4CCF-A646-C346A44A32ADQ40152954-338A2445-8E2F-4A81-B8F8-EF19E245A8E2Q40254133-9976AC61-EBE5-4098-BA4F-2C7DDBDBE1D3Q40355541-CCD222DD-C5F6-4865-812D-48D7A4201702Q40763565-5492AC7E-49D2-47CE-8940-4BE172CCB598
P50
description
researcher
@en
name
M de Bruin
@ast
M de Bruin
@en
M de Bruin
@nl
type
label
M de Bruin
@ast
M de Bruin
@en
M de Bruin
@nl
prefLabel
M de Bruin
@ast
M de Bruin
@en
M de Bruin
@nl
P106
P31
P496
0000-0001-9197-7068